| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |